Related Experiment Video
Updated: Apr 3, 2026

MRI and PET in Mouse Models of Myocardial Infarction
Published on: December 19, 2013
Quantitative myocardial perfusion imaging across PET, SPECT, CMR, and CT
Yoko Kato1, Omar Chehab1, Bharath Ambale-Venkatesh2
1Division of Cardiology, Johns Hopkins University, Baltimore, MD, United States.
Insights
Myocardial perfusion imaging (MPI) is crucial for diagnosing coronary artery disease (CAD) and other heart conditions. Advances in PET, CMR, and CT enable quantitative myocardial blood flow (MBF) assessment, improving diagnostic and prognostic capabilities.
Area of Science:
- Cardiology
- Medical Imaging
- Diagnostic Techniques
Background:
- Coronary computed tomography angiography (CCTA) trials have shifted focus from functional testing.
- Myocardial perfusion imaging (MPI) remains vital for specific patient groups, including those with suspected coronary artery disease (CAD), microvascular dysfunction, and cardiomyopathies.
Purpose of the Study:
- To review the physiological principles, acquisition, and post-processing strategies for MPI.
- To discuss the clinical relevance and future perspectives of quantitative MPI across various imaging modalities.
Main Methods:
- Review of current literature on positron emission tomography (PET), cardiovascular magnetic resonance (CMR), computed tomography (CT), and Single Photon Emission Computed Tomography (SPECT) for MPI.
- Focus on absolute quantification of myocardial blood flow (MBF).
Main Results:
- Advances in PET, CMR, and CT allow for absolute quantification of myocardial blood flow (MBF).
- Quantitative MPI offers improved diagnostic and prognostic performance compared to traditional methods.
Conclusions:
- Quantitative MPI is essential for a comprehensive assessment of myocardial perfusion in diverse cardiovascular conditions.
- There is a need to reappraise the role of MPI in light of technological advancements and new clinical trial data.
Abstract:
Recent clinical trials demonstrating the prognostic value of coronary computed tomography angiography (CCTA), and the limited incremental prognostic benefit of ischemia-guided revascularization over optimal medical therapy, have shifted focus away from functional testing. Nevertheless, myocardial perfusion assessment remains essential in patients with known or suspected coronary artery disease (CAD), microvascular dysfunction, ischemia with normal coronary arteries (INOCA), coronary anomalies, and cardiomyopathies. Advances in positron emission tomography (PET), cardiovascular magnetic resonance (CMR), and computed tomography (CT) now enable absolute quantification of myocardial blood flow (MBF), providing improved diagnostic and prognostic performance and underscoring the need to reappraise myocardial perfusion imaging. This mini-review summarizes key physiological principles, contemporary acquisition and post-processing strategies, and the clinical relevance of myocardial perfusion imaging (MPI) across PET, Single Photon Emission Computed Tomography (SPECT), CMR, and CT, and discusses future perspectives in quantitative MPI.
More Related Videos
11:09High-Resolution Cardiac Positron Emission Tomography/Computed Tomography for Small Animals
Published on: December 16, 2022
08:13In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Related Concept Videos
Imaging Studies for Cardiovascular System V: CT
Imaging Studies for Cardiovascular System IV: CMRI
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...